Objective. This study attempted to identify the effects of SGI on pain outcomes and HRV indices and to determine the association between pain and HRV outcomes.
Design. A prospective double-blind, randomized study.
Setting. An outpatient pain medicine clinic.
Subjects and Methods. A total of 44 patients were enrolled and randomized into the experimental group (n 5 22) and control group (n 5 22). The experimental group received 12 sessions (twice weekly) of standard SGI, whereas the control group received the same protocol with sham irradiation. Pain and HRV were measured before and after each irradiation session. All outcome measures used in the first-and secondhalf treatment courses were analyzed.
Results. Pain and HRV outcome measures of the experimental group significantly improved after SGI when compared with the control group in both courses. Considering time and frequency domains, the changes in HRV in the second-half treatment course exceeded those in the first-half treatment course. Pain was significantly associated with postirradiated HRV indices (P < 0.001).
Introduction
Neuropathic pain syndrome develops from damage to either the peripheral or central nervous system and may manifest its clinical presence through mediation by the sympathetic nervous system. Such sympathetically mediated pain is termed "sympathetically maintained pain" and is often associated with complex regional pain syndrome (CRPS) [1, 2] . It is also a common feature of fibromyalgia, acute herpes zoster, phantom limb pain, traumatic neuropathies, and plexus lesions as well as other diseases associated with alpha adrenergic sensitization [3] [4] [5] . In addition, sympathetically maintained pain has been categorized as a subset of neuropathic pain mediated by the mechanism underlying peripheral sensitization; underlying peripheral sensitization refers to the noradrenergic sensitization of peripheral afferent nociceptive fibers and a pathologically sympathetic-sensory coupling between the efferent sympathetic and afferent sensory system [6, 7] . Moreover, neuropathic pain is associated with vasomotor and sudomotor dysfunction through either peripheral integration by stimulated adrenoreceptors or central integration organized by sensitization [8] [9] [10] . Therefore, modulating the sympathetic activity by using medications or a local sympathetic ganglion blockade may influence the pain course in patients with neuropathic pain [11] .
The pain associated with sympathetic activity can be relieved by blocking the efferent sympathetic nerves to the affected area. Anatomically, the cervicothoracic ganglion, also called stellate ganglion, supplies sympathetic efferent fibers to the hand, neck, head, and heart [12] . Therefore, a stellate ganglion block (SGB) with local anesthetics has been advocated as an early intervention for achieving sympatholysis, and strong evidence of its effectiveness has been reported [13] [14] [15] [16] . However, SGB is an invasive technique that must be performed by a skilled clinician. By contrast, stellate ganglion irradiation (SGI) can be conveniently administered in clinical practice even when an anesthesiologist is unavailable. In addition, researchers have elucidated several potential complications, such as local muscle injury and scarring by repeated injections to the same point; life-threatening inadvertent subarachnoid or intra-arterial injection with an incidence of 1.7 per 1,000 blockades [17] ; esophageal puncture [18] ; retropharyngeal hematoma, which has resulted in fatal respiratory arrest in 1/100,000 cases [19] [20] [21] ; locked-in syndrome [22] ; pneumothorax [20] ; and sinus arrest [23] . Alternatively, irradiating light near the stellate ganglion region by using either a lowlevel laser or linear polarized near-infrared light irradiation has been employed as a noninvasive method for sympathetic blockade. SGI is well tolerated by patients, with no reported thermal injury or side effects. This treatment is also indicated for patients who refuse to receive injections, are undergoing anticoagulant therapy, or have a bleeding disorders such as hemophilia [24] [25] [26] [27] [28] .
Phototherapies of light of various wavelengths have been effectively used for relieving chronic pain caused by CRPS [29] , fibromyalgia [27] , glossodynia [30] , burning mouth syndrome [25, [31] [32] [33] , and other disorders [24, 34] . In particular, SGI has been recently identified as producing several positive effects, including improvements in blood flow by dilating vessels and reduction in pain. This mechanism is similar to those produced by SGB in patients with neuropathic pain by directly blocking the afferent nociceptive signals through sympathetic pathways [25, 27, 32, 34, 35] . However, most studies on treatment outcomes following SGI have mainly focused on changes in pain level, peripheral temperature, and blood flow. Inconsistent findings further highlight the need to clarify whether SGI exerts any effect on the autonomic nervous system (ANS). Heart rate variability (HRV) has been used clinically as an objective and noninvasive marker of the ANS [36, 37] . However, the SGI's effect on HRV as well as the association between changes in HRV and pain relief after SGI remain unclear. Zamuné r et al. reported that higher sympathetic activity driving the cardiovascular system is associated with a higher pain magnitude in patients with fibromyalgia under specific pathological conditions [4] . When the pathogenesis of neuropathic pain is closely associated with an abnormality in ANS function, treatment efficiency in regard to the sympatholytic effect of SGI must be assessed. This effect can be assessed by directly measuring an objective marker of autonomic activity, such as the HRV, rather than by only determining the pain status, local temperature, or peripheral blood flow after SGI. Furthermore, studies that have determined changes of HRV indices after light irradiation have reported that SGI influences ANS function in healthy adults [38] [39] [40] . By contrast, Momota et al. reported that SGI exerted no within-group effect on HRV between the first-and second-half treatment courses in patients responding well to irradiation [33] . The authors further demonstrated a time-dependent effect on differential HRV indices, which were defined as changes in HRV variables immediately after each irradiation session [33] . Therefore, clearly identifying the association between changes in HRV and pain relief following SGI would allow clinicians to establish a standard protocol for SGI phototherapy and to accurately follow the outcomes of autonomic dysfunction in patients with neuropathic pain.
The present study examined the sympatholytic and clinical effects of linear polarized near-infrared irradiation applied near the stellate ganglion region in patients with neuropathic pain. Moreover, we investigated the association between pain status and changes in HRV after SGI treatment. We hypothesized that SGI improves pain and changes HRV and that the improved pain outcome is associated with these subsequent changes to HRV.
Methods

Design
A double-blind, prospective, randomized control trial with two study groups was conducted at the Pain Medicine Center of the Physical Medicine and Rehabilitation Department at Taipei Medical University. Eligible patients were recruited from February 2015 to November 2015. The patients were randomly assigned to either the experimental group (EG) or the control group (CG) by using a table of random numbers. The EG underwent a 6-week standard SGI treatment protocol (12 irradiation sessions), whereas the CG received sham irradiation during the same period. Routine treatment, including regular physiotherapy and medications, were allowed for each patient. All outcome measures were collated by a trained research assistant before and after SGI in each session during the treatment. Informed consent was obtained from each patient prior to the first session. This study was approved by the Joint Institutional Review Board of Taipei Medical University.
Patients
The patients were selected according to the Consolidated Standards of Reporting Trials (CONSORT) Statement's Extension for Non-Pharmacological Trials, as illustrated in Figure 1 [41] . Patients diagnosed with neuropathic pain, including CRPS type 1, postherpetic neuralgia, fibromyalgia, and postsurgery pain, were recruited from the chronic pain center at our hospital. We used the Budapest Criteria [42] to identify CRPS and sympathetically associated pain. Patients' charts were reviewed to determine their eligibility. We excluded patients who satisfied the following criteria: 1) diagnosis of glioblastoma; 2) history of heart disease, serious arrhythmia, or pacemaker use; 3) Simmond disease or postpartum hypopituitarism; 4) habitual smoking or consumption of stimulant beverages, such as tea, coffee, or alcohol; 5) large neck circumference (<43 cm for males; <40.5 cm for females), which is associated with a high risk of respiratory problems during local and general anesthesia [43, 44] ; and 6) any other condition unsuitable for phototherapy, as evaluated by a doctor. Baseline patient characteristics-age, height, weight, sex, body mass index, and upper limb involvement (right, left, or bilateral)-were recorded at admission. The comorbidity status was evaluated for each patient by using the Comorbidity Illness Rating Scale [45] .
Randomization
Patients were randomized into the two study groups by using block allocation with a block size of four [46] . The list was computer generated by the independent randomization center. The principal investigator informed the patients of the treatment schedules generated by the randomization center.
Procedure Involving Light Irradiation to the Stellate Ganglion
SGI was performed by a senior physical therapist by using a linear polarized near-infrared irradiation device, specifically the Minato Alphabeam Infrared Ray Therapy Unit (Minato Medical Science Co., Ltd., Hyogo, Japan). The maximal output was 3,000 mW/cm 2 at wavelengths of 0.7 to 1.6 lm, a range encompassing both visible (red) and near-infrared radiation. The EG received SGI under the following conditions: a light emission head with an diameter of 7 mm; an output of 1,800 mW; irradiation cycle ratio of 1:2 (irradiation for 2 s followed by a 4-s pause); an irradiation duration of 10 minutes with a total irradiated time of 200 s; and two sessions per week with a total irradiation energy of 720 J. Similar to the SGB protocol, the location of the stellate ganglion on the affected side was confirmed at the C6 Chassaignac tubercle through a paratracheal approach described as follows [47] : The patient lay in the supine position with the neck slightly extended and the head slightly turned away from the side being irradiated. The sternocleidomastoid muscle on the irradiated side was then gently retracted, and the probe of the device was firmly and perpendicularly placed against the skin in the jugular groove at a site 2.5 cm above the costoclavicular joint. The region near the stellate ganglion was irradiated, and when the pain was bilateral, SGI was performed on both sides. The instrument used for the CG was the same as that employed for the EG, except that the radiation emitted from the device was inactive for the CG. The investigator set up the irradiation program behind a curtain that separated the machine from the irradiation probe. Therefore, the therapist and patients were both blinded to the active instrument.
Irradiation was performed twice weekly for 6 weeks (12 irradiation sessions). To control for diurnal variation, all sessions were conducted between 1 PM and 5 PM in a quiet, controlled (24 C, 20-50% relative humidity) therapy room. The physical therapist and patients wore goggles during the treatment.
Pain Assessment
The response to SGI was evaluated using a visual analog scale (VAS; 0-100 mm) representing the pain intensity, where 0 represents "no pain" and 100 indicates "unbearable pain." All patients were instructed to indicate a point on the scale corresponding to their pain intensity. The distance from the left end to the selected point was measured for calculating the pain score in millimeters.
HRV Analysis
HRV was measured using an ANSWatch
V R wrist monitor (Taiwan Scientific Co., Taipei, Taiwan) immediately before and after every irradiation session. This previously described monitor employs multiple piezoelectric sensors in the cuff to measure the blood pressure waveforms of the radial artery [48] . HRV variables, including time and frequency domains, were analyzed according to the international standard [37] . Time-domain HRV variables include the standard deviation (SD) of the normal-to-normal (NN) intervals (SDNN; ms), root mean square of successive differences at rest (RMSSD; ms), and the percentage derived by dividing the number of interval differences of successive NN intervals longer than 50 ms by the total number of NN intervals (pNN50, %). Furthermore, frequency-domain HRV variables, determined through the power spectral analysis, include a low-frequency (LF) component (0.04-0.15 Hz, ms 2 ), which is associated with sympathetic activity; a highfrequency (HF) component (0.15-0.4 Hz, ms 2 ), which is mainly considered a marker of vagal (parasympathetic) modulation; ratio of LF to HF (LF/HF), which is suggested to reflect sympathovagal balance; power in extremely LF bands 0.04 Hz (VLF; ms 2 ); total power of the density spectra (TP; ms 2 ); LF power in a normalized unit (LF norm; n.u.); and HF power in a normalized unit (HF norm; n.u.). Regarding device accuracy, the correlation coefficients for HRV parameters range from 0.90 to 1.0 according to electrocardiograms, which served as the control [49] .
The patients were first instructed to quietly rest for 10 minutes in the supine position. They were then each assisted in securing an ANS monitor to the left wrist and instructed to close their eyes, relax, and remain quiet. Each ANSWatch V R test was completed in approximately 7 minutes, and the measured parameters, including standard HRV indices, and the hemodynamic parameters, including blood pressure (BP) and hazard ratio (HR), were outputted. All data were downloaded using the ANSWatch V R Manager Pro (version 1.94) analysis software.
The dichotomy observed between the EG and CG was successfully used for identifying the efficiency of SGI in improving pain outcomes as well as for determining the time-dependent effect on the immediate automatic response to SGI [32] . The treatment effects of SGI were judged from the temporal development of the measured outcome values. The initial six and the subsequent six irradiation sessions represented the first-and secondhalf treatment courses, respectively. The mean value of all parameters in every irradiation session was calculated by averaging six values each during the first and second halves of the total treatment period, with each half comprising six irradiation sessions within 3 weeks.
Sample Size Estimation
The required sample size for this study was estimated on the basis of the VAS score by using G*Power 3 [50] . At a statistical power of 0.85, an effect size of 1.15 [14] , and an alpha value of 0.05, we determined that a Figure 1 Flowchart of patient enrollment. *Data were analyzed under the intention-to-treat principle, and missing data were managed using the last observation carried forward method. minimum of 34 patients (n ¼ 17 for each group) were required to identify a difference in the VAS score of 2 between the 2 patient groups, assuming an SD of the postirradiated VAS score of 0.6 to 2 [14] . Allowing for a dropout rate of 20%, we enrolled 44 patients to ensure an adequate level of statistical power.
Statistical Analysis
Independent t tests and chi-square analyses were used for comparing baseline patient characteristics and outcome measures of the EG with those of the CG. The Kolmogorov-Smirnov test was employed for confirming a normal distribution of all the variables. Natural log transformation (ln) was used if the data were not normally distributed. An intent-to-treat analysis based on the last observation carried forward technique was employed for managing any missing data [51] and for minimizing bias associated with losses to follow-up. The paired t test was used for assessing the differences between the various pretest and posttest values. Differences in the posttest scores between the CG and EG in the first-half and second-half treatment courses were assessed using two-way analysis of covariance by employing the pretest results for both groups as the covariate. For all outcome measures, a Group (EG, CG) Â Irradiation (before, after) Â Time (all 12 sessions) repeated measures analysis of variance (ANOVA) was performed to determine whether the SGI-induced transient effect quickly dissipated or carried over time intervals. When controlling for the irradiation mode and baseline characteristics, associations between the HRV changes and pain outcome were identified using a multiple stepwise linear regression analysis of the collapsed data, in which the postirradiated VAS score was considered the dependent variable and the postirradiated SDNN, RMSSD, pNN50, LF and HF components, LF/HF, TP, VLF, LF norm, and HF norm were all considered the exploratory covariates. The logarithmic transformation of the dependent variable was used for variance stabilization in each multiple regression analysis. P < 0.05 was considered statistically significant. The SPSS Version 17.0 statistical program was used to conduct all analyses.
Results
A total of 52 patients referred from the Pain Medicine Center of the Physical Medicine and Rehabilitation Department were assessed to determine their eligibility for this study. After excluding eight patients who did not satisfy the inclusion criteria (heart disease, n ¼ 3; pacemaker, n ¼ 1; and habitual smoking and coffee consumption, n ¼ 4), 44 patients were enrolled in our study. Informed consent was obtained from all patients, and they were randomized into the EG [n ¼ 22; 17 women and 5 men; age (mean 6 SD), 50.8 6 8.1 years] and CG (n ¼ 22; 19 women and 3 men; age, 49.8 6 6.6 years). During the 6-week study period, one patient dropped out of the EG in the first-half treatment course. In the second-half treatment course, one patient each dropped out of the EG and CG. Finally, 20 and 21 patients from the EG and CG, respectively, completed the follow-up admission in the study. Patients did not report any side effects during treatment. On the basis of the intention-to-treat analysis, the missing data of three patients were managed using the last observation carried forward method. Thus, data of all 44 patients were included in the final analysis (Figure 1 ).
Demographic characteristics of the two groups are presented in Table 1 . No significant difference in the characteristics was observed between the two groups (all P > 0.05). Table 2 presents the pain scores and hemodynamic variables at the two treatment courses as well as the preirradiation changes in both groups. Pain significantly improved in the EG in the first-half and second-half treatment courses, with adjusted mean changes of À 19.1 mm (95% confidence interval [CI]: À21.0, À17.2; P < 0.001) and À34.6 mm (95%CI: À37.1, À32.1; P < 0.001), respectively. However, no significant change was observed in the CG. The change in the pain score in the second-half treatment course was higher than that in the first-half treatment course in the EG (P ¼ 0.001). SGI significantly reduced the HR in the first-half (P < 0.01) and second-half (P < 0.05) treatment courses, whereas no significant change was identified in the CG. Postirradiated systolic BP (SBP) significantly increased in the first-half (P ¼ 0.004) and second-half (P ¼ 0.025) treatment courses, whereas no significant change was observed in the CG. No significant change was identified in diastolic BP after either standard or sham irradiation. Figure 2 presents the adjusted mean value of HRV measures after standard SGI and sham irradiation in the EG and CG, respectively, in the first-and second-half treatment courses. Intragroup differences between the two treatment courses were observed in the EG. During the second-half treatment course, the postirradiated HRV variables were either significantly higher (SDNN, RMSSD, pNN50, lnTP, lnVLF, lnHF, and HF norm) or significantly lower (LF norm, and LF/HF) than the HRV variables observed in the first-half treatment course (all P < 0.01). Moreover, intergroup differences were observed in all HRV measures between the two groups in the second-half treatment course (all P < 0.01), and those in the first-half treatment course were also found (all P < 0.01). No significant difference in postirradiation HRV was identified between the two treatment courses in the CG. Table 3 presents the adjusted mean changes in HRV measures immediately after the two groups were irradiated during both treatment courses. The changes in HRV measures, namely in SDNN (P ¼ 0.018), PNN50 (P ¼ 0.005), lnLF (P ¼ 0.022), LF norm (P < 0.001), and HF norm (P < 0.001), immediately after standard SGI in the second-half treatment course were significantly higher than those in the first-half treatment course for the EG. Table 4 lists the results of the repeated measures ANOVA. Significant group effects were seen for VAS pain score and all other measures (all P < 0.001), except SBP and diastolic blood pressure (DBP). No significant time effect was found for all measures (all P > 0.05). Significant interactions between group and time for VAS (P < 0.001) as well as all between group and HRV measures (all P < 0.05) were observed. Adjusted mean values of measures (including VAS, SDNN, lnLF, and LF/HF) before and after irradiation over all treatment sessions are presented in Figure 3 .
Pearson correlation analysis revealed that all postirradiated time-and frequency-domain HRV variables moderately to strongly correlate with pain outcomes after SGI (all P < 0.001). Table 5 shows correlations between the variables entered into the regression analyses. For establishing a linear regression model with collapsed data, all HRV variables were entered in a stepwise mode. Multiple linear regression analyses were performed using the postirradiated data in each session (Table 6 ). After controlling for baseline characteristics, the results indicated that pain improvement was associated with postirradiated HRV outcomes (P < 0.001) in the EG during the 6-week SGI intervention.
Discussion
The present study revealed that patients with neuropathic pain benefitted from treatment with SGI. Observed benefits included pain relief (represented by an improved VAS pain score), decreased sympathetic hyperactivity (indicated by increased SDNN and decreased LF norm), and the integration of sympathovagal balance (represented by improved LF/HF). Moreover, the decreased pain after SGI was significantly associated with improved HRV measures, including SDNN, RMSSD, pNN50, LF and HF components, LF/HF, LF norm, and VLF.
As an alternative to traditional SGB, transcutaneous light irradiation using a low-intensity laser or linear polarized near-infrared light near the stellate ganglion region was successfully employed as a noninvasive clinical application for managing a sympathetic blockade without any reported complications or side effects [24] [25] [26] [27] [28] [29] 33, 52, 53] . The stellate ganglion is a fused sympathetic ganglion formed by the inferior cervical and T1 ganglion in 80% of people. It is located in front of the neck of the first rib, extends to the interspace between C7 and T1 vertebral bodies, and lies medially to the scalene muscles, laterally to the longus colli muscle, and anteriorly at the level of the C7 transverse process [54, 55] . The stellate ganglion can be irradiated using linear polarized nearinfrared light with high permeability because of its long wavelengths, enabling light energy to more deeply penetrate tissues. In addition, the wavelength range within the near-infrared region poses a low risk of burns and minimal absorption by water, melanin, and hemoglobin. This light energy can be increased while inhibiting thermal energy by using pulse waves that employ a pulse width shorter than the time required for thermal diffusion. In our study, all patients strongly complied with their irradiation programs, and no side effects or other complications were reported.
Previous studies have found that a suppressed hyperactive sympathetic outflow following successful SGI represents decreased HR, increased SBP, increased peripheral arterial blood flow, increased peripheral temperature, and decreased pain [30, 34, 35, 56] . In our study, SGI significantly reduced HR, increased SBP, and improved the VAS score. These observations were similar to those following the use of an SGB [35, [57] [58] [59] , indicating the clinical efficiency of SGI for treating a sympathetic blockade.
The underlying mechanism that mediates the effects of SGI on pain relief and cardiovascular response remains unclear. However, symptom relief after SGI has been attributed to changes in local blood flow at the site of pain [30, 34, 56, [60] [61] [62] . Overactivity of the sympathetic nervous system has been postulated to be suppressed following SGI because of the similar sympatholytic effects of SGB [35, 63] . SGI may relieve vasospasm of peripheral vessels at the local site and is followed by an increase in blood flow to the site of pain, thereby improving the symptoms.
HRV analyses have served as noninvasive objective clinical markers of ANS function [64] [65] [66] [67] , and HRV indices are widely used as measures of treatment outcomes for patients receiving pain management [25, 29, 33, 38, [68] [69] [70] . Patients under stress or with a pain disorder have been reported to have a diminished time-domain HRV and a higher frequency-domain HRV compared with healthy controls [64] [65] [66] [67] [71] [72] [73] , whereas Figure 2 Adjusted mean values of heart rate variability immediately after stellate ganglion irradiation during the firstand second-half treatment courses. All data were adjusted values of measures before irradiation. Error bars represent the 95% confidence interval. *A significant difference compared with the control group; # a significant difference compared with the first-half treatment course. SDNN ¼ standard deviation of the normal-to-normal (NN) intervals; RMSSD ¼ root mean square of successive differences at rest; pNN50 ¼ percentage derived by dividing the number of interval differences of successive NN intervals longer than 50 ms by the total number of NN intervals; lnTP ¼ natural log-transformed total power; lnVLF ¼ natural log-transformed very-low-frequency power; lnLF ¼ natural log-transformed low-frequency power; lnHF ¼ natural log-transformed high-frequency power; LF norm ¼ LF power in normalized units; HF norm ¼ HF power in normalized units; LF/HF ¼ ratio of LF to HF. the discrepancy in HRV indices between patients and their age-matched healthy controls would be reduced after pain management [65, 68] . Healthy controls were not included in this study; therefore, we could not directly investigate the association between improved HRV and the health status of our patients. However, improved HRV indices have been associated with lower pain, lesser disease severity, and higher quality of life [4, 64, 65, 74, 75] . Under such circumstances, patients with improved HRV that engage in pain management seem to achieve an improved health status. Our results demonstrated that patients receiving SGI reached an improved HRV status with increased SDNN, decreased LF norm, increased HF norm, and decreased sympathovagal imbalance (LF/HF), possibly allowing for more optimal health outcomes. Intention-to-treat analysis: N ¼ 44 (experimental n ¼ 22 and control n ¼ 22). ¶ CG ¼ control group; EG ¼ experimental group; SDNN ¼ standard deviation of the normal-to-normal (NN) intervals; RMSSD ¼ root mean square of successive differences at rest; pNN50 ¼ percentage derived by dividing the number of interval differences of successive NN intervals longer than 50 ms by the total number of NN intervals; lnTP ¼ natural log transformed total power; lnVLF ¼ natural log transformed very low frequency power; lnLF ¼ natural log transformed low frequency power; lnHF ¼ natural log transformed high frequency power; The heart receives a bilateral sympathetic supply from the cervical ganglia and upper thoracic spinal nerves 4 and 5; therefore, a successful procedure that targets the stellate ganglion decreases the sympathetic outflow to the heart. This change may consequently mainly influence a subset of the cardiovascular sympathetic supply, regardless of the side of application. However, previous studies have reported that SGB with invasive (i.e., pharmacology) or noninvasive (i.e., light irradiation) approaches would also change the activity level of the parasympathetic nerve system (i.e., changes in HF) or sympathovagal balance (i.e., changes in LF/HF) [76] [77] [78] [79] [80] . Our study also demonstrated that SGI not only suppressed sympathetic activity by lowering lnLF and LF norm but also elevated parasympathetic level by increasing the lnHF and HF norm. Following invasive or noninvasive SGB, changes in both the sympathetic and parasympathetic influence on the sinus node may improve the sympathovagal imbalance, which inconsistently counterbalances and changes the RR interval.
A frequency-domain analysis may be more satisfactory than a time-domain analysis in precisely evaluating changes in sympathovagal balance. Momota et al. identified a time-dependent effect on immediate changes in frequency-domain HRV indices, which is consistent with our findings. However, they failed to identify the withingroup difference of frequency-domain HRV outcomes between the first-and second-half treatment courses. In contrast to the findings of Momota et al., our patients receiving standard SGI exhibited a higher HF component and a lower LF/HF in the second-half treatment course than in the first-half treatment course. This inconsistency in efficacy may be attributed to the different levels of SGI applied in our study and in that of Momota et al. Each week, our patients received a higher and more frequent irradiation dose, which may have promoted the efficiency of postirradiated HRV, enabling the SGI efficacy to be dose-dependent, regardless of the irradiation form [81] . In addition, Yoshida reported that SGI increased the HF component and reduced LF/HF Figure 3 Adjusted mean values of (a) visual analog score; (b) standard deviation of the normal-to-normal (SDNN); (c) natural log-transformed low-frequency power (lnLF); (d) ratio of low-frequency power to high-frequency power (LF/HF) before and after irradiation over all treatment sessions. All data were adjusted for the pretest results, age, sex, body mass index, side of irradiation, and the Cumulative Illness Rating Scale score. Error bars represent the standard error. *A significant difference compared with the posttest of sham irradiation group, P < 0.05; ** P < 0.01; *** P < 0.001. SGI ¼ light irradiation to the region near the stellate ganglion.
[38]. Similar results were also observed after SGB use [78] . These findings indicate that vagal-dominant integration after SGI further results in improvements in sympathovagal imbalance in patients with neuropathic or chronic pain associated with autonomic dysfunction.
Previous studies have used SGI for pain management, and their results have revealed significant sudomotor responses involving either an increase in the peripheral blood flow or local temperature at the referral limb. However, these results cannot completely explain the association between pain relief and autonomic regulation because pain may be sympathetically independent. We directly determined the association between the postirradiated pain status and autonomic function by analyzing HRV and observed that pain improvement was significantly associated with the HRV following SGI. Our findings are supported by those reported by Zamuner and colleagues, who demonstrated that pain intensity is associated with sympathetic hyperactivity in patients with pain disorders [4] , further indicating that modulating sympathetic overflow or integrating sympathovagal imbalance enables pain improvement.
Blood pressure can be inhibited by hyperalgesia or mediated by the autonomic nerve system. Blocking afferent impulse from the left vagal afferents or diminishing aortic depressor nerve discharge may trigger a significant baroreflex-induced increase in blood pressure, whereas blockade of cardiac sympathetic outflow by local anesthetics to the stellate ganglion is usually followed by an expected reduction in blood pressure [82] . In addition, blood pressure is inversely related to ischemic pain sensitivity or a hypoalgesic response [83] . The underlying mechanisms by which such hypoalgesic effect mediates blood pressure remain unclear. Alternatively, a change in central nervous system pathways may contribute to the association between increased blood pressure and decreased pain sensitivity. Endogenous opiate activation, such as with levels of circulating b-endorphin mediated by the hypothalamus endocrine system, may explain the relationship between blood pressure and pain in response to sympathetic suppression by SGB [84] . Our study demonstrated a statistically significant increase in systolic blood pressure immediately after SGI ( Table 2 ). Previous studies have reported results that are contrary to an immediate sympatholytic response in blood pressure [56, 79, 85, 86] , regardless of the side where SGB was performed. These results imply that both elevated blood pressure and decreased pain (hypoalgesic response) following suppression of sympathetic tone may be independent events mediated by central processing pathways that impact both autonomic outflow and nociceptive afferents. Further research is necessary to confirm the association between the hypoalgesic response and changes in blood pressure after SGI. Additional studies are also needed to elucidate how such hypoalgesic effects mediate the changes in blood pressure following SGI.
Our findings do have some limitations. First, our study design lacked a healthy CG to ascertain if the intervention effects resulted from natural recovery of ANS function. Second, only patients with neuropathic pain were included in our study. Therefore, our results might not be generalizable to other types of pain disorders. Future investigations are warranted to establish whether using SGI can improve pain outcomes or the quality of life in patients with other diagnoses such as CRPS.
Conclusions
The present prospective study revealed that 6 weeks of SGI improved pain and autonomic dysfunction outcomes in patients with neuropathic pain. In addition, reductions in pain were associated with improved time and frequency domains of HRV indices following SGI. Considering the impact of sympathovagal imbalance on pain outcomes, we suggest focusing on modulating ANS deregulation for pain management in patients with neuropathic pain. Our findings could assist clinicians in determining the optimal parameters required for SGI application.
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